LifeSci Capital
LifeSci Capital is a New York–based boutique investment bank founded in 2010 that provides equity research, investment banking, and equity capital markets services exclusively to emerging life sciences and healthcare companies, covering 89 issuers and having executed 159 IPOs and secondary transactions.
- Company typePrivate
- Founded2010
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What LifeSci Capital does
LifeSci Capital is a New York–based boutique investment bank organized as LifeSci Capital, LLC and founded in 2010, providing services exclusively to emerging life sciences and healthcare companies. The firm operates three integrated service lines: Equity Research, Investment Banking, and Equity Capital Markets. Its research team is differentiated by domain expertise, with more than half of research staff holding MA, PhD, or MD degrees, producing "deep dive" analyses distributed openly to top institutional investors, covered companies, and biopharma leadership without commission collection from institutions.
The firm's investment banking practice covers mergers and acquisitions advisory, private capital advisory, equity and debt capital markets execution, and SPAC financings for healthcare and life sciences clients. Equity Capital Markets activities pair research with investor engagement, including approximately 50 non-deal roadshows per year averaging 10 meetings each, plus 132 investor events executed across 2024 and 2025 (90 in-person and 42 virtual). The firm has completed 159 IPOs and secondary transactions with an average deal size of $212.6 million, and currently covers 89 companies with an average market cap of $2,320 million.
LifeSci Capital generates revenue through transaction-based investment banking advisory fees, bookrunning and placement fees on public offerings and private placements, and equity research distribution services to institutional investors. Geographically, the firm serves clients across North America, Europe, and Israel, and is part of the broader LifeSci platform alongside affiliated advisory firm LifeSci Partners. The firm is a member of SIPC and FINRA and maintains approximately 50 team members across research, investment banking, trading, and institutional sales functions.
LifeSci Capital firmographics
Firmographics- Name
- LifeSci Capital
- Legal name
- LifeSci Capital, LLC
- Website
- https://lifescicapital.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- LifeSci Capital is a New York–based boutique investment bank founded in 2010 that provides equity research, investment banking, and equity capital markets services exclusively to emerging life sciences and healthcare companies, covering 89 issuers and having executed 159 IPOs and secondary transactions.
- Ownership category
- akta.pro rank
LifeSci Capital industry classification
Industry- Product category
- Investment Banking & Life Sciences Advisory
- NAICS
- Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211)
- akta.pro primary industry
- Capital Raising Advisory (Equity & Equity-Linked) (FSAEAGAC)
- akta.pro secondary industries
- Equity Capital Advisory (Private Equity Placements, Growth Capital) (BPAHAOAE), Capital Raising Advisory (Debt/Equity/Private Capital) (BPAHADAG)
Keywords
Where LifeSci Capital is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
LifeSci Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Investment Banking Advisory Fees: Revenue generated from corporate finance advisory, mergers and acquisitions advisory, and capital markets execution services for life sciences companies.
- Bookrunning and Placement Fees: Revenue from acting as bookrunner, co-lead manager, or placement agent for public offerings, private placements, and other equity capital markets transactions.
- Equity Research Services: Research distribution services to institutional investors, generating value through raising visibility of covered companies.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
LifeSci Capital product offering
Product offeringCore offering
LifeSci Capital is a boutique investment bank dedicated to life sciences and healthcare companies, providing equity research coverage of approximately 89 issuers, investment banking advisory (capital raising, M&A, IPOs and secondary offerings), and equity capital markets execution. The firm pairs sector-specialized analysts with institutional investors via an open-distribution research model and non-deal roadshows, with a cumulative track record of 159 IPOs and secondary transactions at an average deal size of approximately $212.6M.
Product overview
LifeSci Capital is a boutique investment bank offering a unified platform of three core services: Equity Research (expert-driven analysis on 89 life sciences companies with 50+ NDRs per year), Investment Banking (M&A advisory, capital markets execution), and Equity Capital Markets (investor engagement activities). The company facilitates IPOs and secondary transactions, with an average deal size of $212.6M and 159 transactions completed.
Differentiator
Problem solved
Functional benefit
Products and services
- Equity Research Equity research coverage on approximately 89 life sciences and healthcare companies, distributed through an open-access model (without commission- or soft-dollar-based gating) to institutional investors. The service pairs sector-specialist PhD/MD-credentialed analysts with investors for direct scientific and clinical diligence, supplemented by approximately 50 non-deal roadshows per year.
- Investment Banking Investment banking advisory for life sciences and healthcare issuers, covering capital raising, M&A, IPOs, secondary offerings, and strategic alternatives. Cumulative track record of 159 completed IPOs and secondary transactions with an average deal size of approximately $212.6M.
- Equity Capital Markets Equity capital markets execution services for life sciences and healthcare issuers, including IPOs, follow-on offerings, and secondary transactions. Distribution supported by institutional investor relationships and approximately 50 non-deal roadshows per year, with an average observed deal size of approximately $212.6M.
Quantifiable outcome
- 159 IPOs & Secondary Transactions with average deal size of $212.6M
- +1 more outcomes
Companies that use LifeSci Capital
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
LifeSci Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
LifeSci Capital partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- LifeSci PartnersplatformLifeSci Capital is part of the LifeSci platform, which includes LifeSci Partners providing additional life sciences advisory services. The platform provides comprehensive services to the life sciences sector.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
LifeSci Capital competitors and assessment
Company assessmentDirect peers
- Leerink Partners (SVB Securities): Healthcare-focused boutique investment bank that historically served as the most direct specialist competitor to LifeSci Capital, providing equity research, ECM, and M&A advisory to life sciences issuers — LifeSci is explicitly named alongside Leerink as a co-deal partner.
- H.C. Wainwright & Co. Small-cap life sciences boutique investment bank providing equity research, capital markets, and advisory services to emerging biotech and healthcare companies — directly overlapping with LifeSci's coverage universe and average deal size profile.
- Roth Capital Partners: Boutique investment bank with a dedicated life sciences and healthcare group focused on small and micro-cap biotech capital raising, research, and advisory — a close comparable in scale and client profile to LifeSci Capital.
- ThinkEquity: Small-cap focused investment bank with a life sciences practice providing research, ECM, and advisory to emerging biotech issuers — directly comparable boutique competitor targeting similar deal sizes and issuer profile.
Broad incumbents
- Jefferies Healthcare Group: Mid-size full-service investment bank with a deep healthcare and life sciences franchise offering ECM, M&A, and research — named as a frequent LifeSci co-deal partner and a key competitor for healthcare mandates.
- TD Cowen (Health Care): Diversified investment bank with a dedicated healthcare investment banking group providing equity research, ECM, and advisory to biopharma and healthcare companies — a named LifeSci co-deal partner and broader-scope competitor.
- Guggenheim Securities (Healthcare): Diversified investment bank with a healthcare and life sciences group offering ECM, M&A, and equity research — a frequent LifeSci co-manager on healthcare transactions and a comparable with broader product reach.
- Piper Sandler (Healthcare): Mid-market full-service investment bank with a sizable healthcare investment banking franchise covering biotech, medtech, and services — competes for similar emerging-growth healthcare mandates as LifeSci.
- Canaccord Genuity (Healthcare): Global mid-market investment bank with a healthcare and life sciences group providing equity research, ECM, and advisory to emerging biotech issuers — a broader but comparable competitor in the small/mid-cap life sciences space.
- Robert W. Baird (Healthcare): Diversified mid-market investment bank with a healthcare investment banking practice providing ECM, M&A, and equity research to mid-cap life sciences companies — a larger, diversified competitor targeting overlapping issuers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
LifeSci Capital social profiles
Digital presenceLifeSci Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
LifeSci Capital leadership team
Management profileNumber of profiles
Profiles2 records
LifeSci Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LifeSci Capital M&A and investment
M&A and investmentM&A
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LifeSci Capital
What does LifeSci Capital do?
LifeSci Capital is a boutique investment bank dedicated to life sciences and healthcare companies, providing equity research coverage of approximately 89 issuers, investment banking advisory (capital raising, M&A, IPOs and secondary offerings), and equity capital markets execution. The firm pairs sector-specialized analysts with institutional investors via an open-distribution research model and non-deal roadshows, with a cumulative track record of 159 IPOs and secondary transactions at an average deal size of approximately $212.6M.
Is LifeSci Capital a public or private company?
LifeSci Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was LifeSci Capital founded?
LifeSci Capital was founded in 2010. It employs 11 to 50 people.
Where is LifeSci Capital based?
LifeSci Capital is headquartered in New York, United States, in the North America region.
How does LifeSci Capital make money?
Three revenue lines are on record. Investment Banking Advisory Fees are the primary driver. The others are bookrunning and Placement Fees and equity Research Services.
Who are LifeSci Capital's main competitors?
Direct peers on record are Leerink Partners (SVB Securities), H.C. Wainwright & Co., Roth Capital Partners and ThinkEquity. Broad incumbents are Jefferies Healthcare Group, TD Cowen (Health Care), Guggenheim Securities (Healthcare), Piper Sandler (Healthcare), Canaccord Genuity (Healthcare) and Robert W. Baird (Healthcare).
Does LifeSci Capital have an API?
No public API is recorded for LifeSci Capital.
What industry is LifeSci Capital in?
LifeSci Capital's product category is Investment Banking & Life Sciences Advisory. Its primary akta.pro industry code is FSAEAGAC, Capital Raising Advisory (Equity & Equity-Linked), with a secondary code of BPAHAOAE, Equity Capital Advisory (Private Equity Placements, Growth Capital). Its NAICS code is 523 and its SIC code is 6211.